https://infectious-diseases-conferences.magnusgroup.org/ 1.0 https://infectious-diseases-conferences.magnusgroup.org/cpd-accreditation 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions 0.9 https://infectious-diseases-conferences.magnusgroup.org/information/venue 0.9 https://infectious-diseases-conferences.magnusgroup.org/information/accommodation 0.9 https://infectious-diseases-conferences.magnusgroup.org/information/guidelines 0.9 https://infectious-diseases-conferences.magnusgroup.org/information/faq 0.9 https://infectious-diseases-conferences.magnusgroup.org/information/important-dates 0.9 https://infectious-diseases-conferences.magnusgroup.org/information/conference-brochure 0.9 https://infectious-diseases-conferences.magnusgroup.org/about/past-events 0.9 https://infectious-diseases-conferences.magnusgroup.org/about/about-organizer 0.9 https://infectious-diseases-conferences.magnusgroup.org/about/testimonials-reviews 0.9 https://infectious-diseases-conferences.magnusgroup.org/contact 0.9 https://infectious-diseases-conferences.magnusgroup.org/submit-abstract 0.9 https://infectious-diseases-conferences.magnusgroup.org/register 0.9 https://infectious-diseases-conferences.magnusgroup.org/privacy-policy 0.9 https://infectious-diseases-conferences.magnusgroup.org/terms-and-conditions 0.9 https://infectious-diseases-conferences.magnusgroup.org/scientific-committee/2026 0.8 https://infectious-diseases-conferences.magnusgroup.org/scientific-committee/2025 0.8 https://infectious-diseases-conferences.magnusgroup.org/scientific-committee/2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/scientific-committee/2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/scientific-committee/2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/scientific-committee/2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/2026 2026-05-30 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/2025 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/wcid-2020 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/wcid-november-2020 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/wcid-september-2020 0.8 https://infectious-diseases-conferences.magnusgroup.org/speakers/wcid-august-2020 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/richard-dembo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/neelesh-sathish 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shahreen-islam-raisa 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/patricia-tai 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shivadarshini-ramachandran 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yu-chen-wu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ekaterina-zueva 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/michel-bellaiche 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/pablo-daniel-roque 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yujeong-na 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mahmoud-mohamed 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/achut-babu-ojha 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/martha-mercado 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/wenli-cao 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/liu-yan 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yassein-m-ibrahim 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sayantani-datta 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/debayan-das 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/pooja-bagdi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sushil-kumar-choudhary 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/prasanth-chandrasekhar-bhat 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/atul-garg 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/emmanuel-joseph-m-mamaril 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/fauzio-nurul-khaira 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/alvin-arif 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rohayat-bilmahdi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/refat-sadeq 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/imen-larbi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ainur-zh-kussainova 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/surendra-gaire 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/toure-amidou 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/chuchu-churko 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/temesgen-kabeta-chala 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/deresse-daka 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/malik-olatunde-oduoye 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nguena-guefack-noumedem-ranyl 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sohyun-park 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/k-m-yacob 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shiva-kashyap-yellavajhala 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/aishwarika-mitra 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/silviya-stoyanova 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/priscilla-suleman-johnstone 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/haftay-abraha-tadesse 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ajiji-azi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/suleiman-kawu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/isaac-bakare 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/reza-nassiri 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/saurabh-chattopadhyay 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/stephen-hsu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/victor-j-alexander 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mohammed-ahmed-garout 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hemanta-kumar-kar 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/johnson-j-h-wang 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nikolas-minanov 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/satya-chitturi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ali-ejaz 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/pawandeep-kaur 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nicole-sonia-northover 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/erika-nnodi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/david-s-buchinsky 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/carson-bridgers 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/omar-malik 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hirotomo-dochi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/kole-winebrenner 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yomna-abdelghani 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/d-anna-marie-edwards 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/simone-hunter 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/patrizia-russo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/agata-bancerz-kisiel 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/matheus-de-oliveira-nogueira 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/esra-cakmak-taskin 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/zeynep-burcin-yilmaz 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yair-lara-blanco 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hannah-ghazi-abid 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/valeria-gordillo-leo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/anila-cake 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/dong-s-li 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/xiaojun-shen 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/eric-tsao 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jian-shen 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/asha-kumari-verma 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/deepak-jacob 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rakshand-shetty 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/asmabanu-shaikh 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/bhavita-prajapati 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/kapil-goel 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sukesh-gerard 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/dhrubajyoti-j-debnath 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/percival-calixto-dilla 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/deen-mark-g-toroy 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/karol-ann-stefania-montufar-melo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/manuel-antonio-sierra-santos 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/niranjan-nayak 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/succes-brege-albert-bouangui-bazolana 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/som-dipielte-estelle-mireille 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/diomande-jean-louty 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/navpreet-singh 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/zamina-bi-yourou-guillaume 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/francis-j-castellino 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/albert-j-eid 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jamie-platt 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/qingxiang-liu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mazen-a-hasan 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mehwish-zeb 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/alaa-abdelmageed-ahmed 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/kadesh-abigail-daniels 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/katherine-sommers 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hemant-garg 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/muhammad-hussain 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sina-hedayatpour 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/prachi-bhanvadia 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/lee-susanne 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/amr-mousa 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/christof-peter-ziaja 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rosemeire-cristina-linhari-rodrigues-pietro 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/baihetinisha-tuerdi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/wei-jia-li 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hua-luo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/xue-bai 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/xinxin-wang 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/harald-eugen-helling 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sunit-mathur 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sabiha-imran 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shikha 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/anant-marathe 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/riti-sanghvi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ishwerpreet-kaur-jawanda 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ghazala-rubi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/zandiswa-m-gulube 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mmuoegbulam-augusta-oluchi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ranjan-ramasamy 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yongqing-li 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/astagneau-pascal 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/stephen-brand 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/paul-michael-petersen 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/silvia-giono-cerezo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shyam-sundar 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/michael-silverman 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jacob-kocher 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/william-song 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/austin-auyeung 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rebecca-yao 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/emma-whittle 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nicole-messere 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rabab-elsadek 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/amulya-prakash 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/chanakya-kodishala 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/catherine-lawton 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/kaydeen-morris-whyte 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rahul-gomez 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mason-torve 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nicole-vieira-pires 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/anna-kloc 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sheeba-samuel-sawant 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/dharanga-rumeshi-ratnayake 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/babl-sabrina 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jiewen-guan 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/anju-kaushal 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/thea-hein-petersen 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/aneta-nitsch-osuch 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/artemisia-ntoula 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/chryso-theodorou-pallari 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/francesca-grippi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/santina-di-bella 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/francesca-gucciardi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/valeria-blanda 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/tamara-mamaeva 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rahul-kumar 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sunita-girish 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/megha-priyadarshi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/harshavardhini-kommavarapu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/kundoly-velayudhan-suseela 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/chital-naresh 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/neelaiah-siddaraju 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/khursheed-ul-islam-ganaie 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ming-shi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/abduh-abdullah-abdulwahab-murshed 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/wenqing-yang 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/haoran-ren 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/dana-gangoo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mihai-ciubotaru 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/thanh-huy-nguyen 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/gyaltsen-dakpa 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/huseynov-elchin-mammad 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/suchada-suphanpayak 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/alok-kafle 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/abu-syed-md-mosaddek 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/majda-bouraddane 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/muhiddin-fayazov 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mukhayyo-khodjaeva 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nozethu-mjokane 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/nhlayiso-atalia-maswanganyi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/esete-assefa-yigezu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/tsedey-damtew-delelegn 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shabnam-hajiani-ghotbabadi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/delia-teresa-sponza 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/caroline-bilen 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/vijay-prabha 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/maria-guadalupe-cordova-espinoza 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rebekah-a-davis 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/julia-palmieri-de-oliveira 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/konstantina-chrysouli 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/frank-hui 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ngwe-moe-khine 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/taif-shah 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shagufta-rather 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/priya-yadav 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/s-ahamed 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sayan-bhattacharyya 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jekishan-hirapara 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/gowtham-reddy-nomula 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/heather-abigail-g-gutierrez 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/s-kishore 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/marie-kathleen-uy-huang-chih-chang 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shane-b-villamonte 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/julie-christie-g-visperas 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/tapanut-songkasupa 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/lomega-jean 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/mikenson-dorcinvil 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jacquet-dareus-elphana 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rose-anaelle-pierre-jean-freycinet 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/edna-ariste 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/berger-saintius 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/evan-miller 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shweta-kelkar 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rigoberto-fimia-duarte 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/yazenia-linares-vega 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/calarasu-cristina 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/maduike-c-o-ezeibe 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/scott-j-kush 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/uttam-ghosh 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/djeamsly-salomon 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/huang-wei-ling 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/sarah-el-nakeep 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/pin-chieh-wu 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/amarjeet-gambhir 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/gayatri-tripathi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/debdeep-mitra 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/subrahmanyam-d-k-s 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ambresh-s-badad 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/irina-nesterova 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/adam-cadesky 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ivelina-trifonva 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jacob-baker 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shaalina-nair 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/balamurugan 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rosalie-walinsundin 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jyacinth-lucille-y-siapno 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/maria-joriselle-origenes-manalo 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jenalyn-s-salasac 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/tatenuma-katsuyoshi 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/flavien-mrguerie 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/spaziani-fabio 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/doaa-abdallah 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hector-javier-gallardo-valencia 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/lydia-mbatidde 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/rajeev-soni 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/ergys-ramosaco 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/shyamapada-mandal 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/pooyan-afzali-harsini 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/hai-v-le 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jola-karaj 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/jason-tong 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/erzheny-tsybikova 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/eduardo-guimaraes-de-araujo-moreira 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/amanda-henriques-cavalheiro 0.8 https://infectious-diseases-conferences.magnusgroup.org/speaker/noa-eliakim-raz 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026 2026-05-30 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/phenotypic-characterisation-of-non-tuberculous-mycobacterium-species-isolated-from-clinical-specimens 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/an-unprecedented-west-nile-virus-outbreak-in-israel-2024-a-textbook-case-for-the-one-health-approach 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/the-bariloche-model-municipal-governance-for-urban-animal-health-and-zoonotic-disease-prevention 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/progress-in-diagnosis-and-treatment-in-elderly-patients-with-tuberculosis-obstructive-pulmonary-disease 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/synergistic-nebulized-therapy-for-severe-viral-pneumonia-a-biomimetic-nano-platform-integrating-msc-derived-exosomes-and-interferon-2b 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/nebulized-mesenchymal-stem-cell-derived-exosomes-encapsulating-interferon-2b-a-synergistic-strategy-for-targeted-treatment-of-severe-viral-pneumonia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/role-of-health-workers-in-the-management-of-mass-drug-administration-in-lymphatic-filariasis-elimination-program-of-nepal-a-mixed-method-study 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/role-of-serial-blood-cultures-24-hours-in-the-evaluation-of-suspected-neonatal-sepsis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/determining-the-prevalence-of-primary-and-secondary-central-line-associated-bloodstream-infection-clabsi-at-the-tertiary-care-hospital 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/detection-of-the-rpob-gene-of-rifampicin-resistant-mycobacterium-tuberculosis-at-the-angr-university-hospital-in-2024-ivory-coast 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/exploring-the-health-seeking-journeys-of-individuals-affected-by-leprosy-lived-experiences-in-selected-urban-rehabilitation-centers-in-ethiopia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/measles-resurgence-in-the-united-states-epidemiological-patterns-and-the-impact-of-digital-misinformation 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/carbapenem-resistance-and-carbapenemases-in-bloodstream-enterobacterales-busan-south-korea-2018-2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/atomic-watchtower-a-multi-modal-machine-learning-framework-for-swift-antimicrobial-resistance-prediction-using-whole-genome-sequencing-and-smiles-based-molecular-mapping 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/prevalence-antifungal-susceptibility-patterns-and-associated-factors-of-candida-species-among-hiv-positive-individuals-with-oropharyngeal-infections-attending-mekelle-health-facilities-of-tigray-northern-ethiopia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/detection-of-single-nucleotide-polymorphisms-as-biomarker-of-benzimidazole-resistance-in-hookworms-among-hiv-positive-and-hiv-negative-patients-in-plateau-state-nigeria 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/linezolid-induced-bicytopenia-in-a-patient-with-end-stage-renal-disease-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/investigating-fusion-loop-modifications-as-a-strategy-to-limit-flavivirus-neuroinvasion 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/detection-limits-of-parti-seqtm-in-host-depleted-blood-a-biological-perspective-using-mycobacterium-smegmatis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/peptide-protein-conjugates-as-vaccine-candidates-against-hookworm-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/camostat-polysaccharide-dual-action-nasal-spray-for-mucosal-barrier-driven-prevention-of-viral-infections 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/rabies-surveillance-and-dog-population-management-insights-from-a-survey-of-roaming-dogs-in-qatar-2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/assessment-of-normalization-factors-in-sars-cov-2-trends-at-four-treatment-plants-basis-for-a-wastewater-surveillance-in-mexico-city 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/nuclear-tug-of-war-competitive-vdr-rxr-nfat1-regulation-of-coronin-1-governs-mycobacterial-survival 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/mycobacterium-tuberculosis-virulence-factor-esat-6-induces-biphasic-immunometabolic-reprogramming-to-redirect-macrophage-polarization 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/phenotypic-and-genotypic-characterization-of-parainfluenza-virus-5-isolated-from-diarrheic-piglets-highlights-its-zoonotic-potential 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/counting-spores-a-case-of-mixed-fungal-infection-candidal-ecthyma-gangrenosum-and-invasive-pulmonary-aspergillosis-in-a-patient-with-acute-myeloid-leukemia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/association-of-high-sofa-score-10-with-elevated-proenkephalin-levels-in-septic-critically-ill-patients-a-single-center-cohort-study-from-indonesia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/comparative-prognostic-performance-of-lactate-proenkephalin-sofa-proenkephalin-and-triple-combination-models-for-early-mortality-prediction-in-septic-critically-ill-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/first-report-of-west-nile-virus-infections-in-horses-in-tunisia-from-2018-to-2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/the-role-of-the-abo-blood-group-system-in-plasmodium-falciparum-disease-severity 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/assessing-risk-factors-for-visceral-leishmaniasis-outbreak-in-south-omo-zone-southern-ethiopia-implications-for-tailored-intervention-strategies 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/antimicrobial-resistance-profiles-of-escherichia-coli-o157-and-salmonella-enterica-isolated-from-ruminants-and-risk-for-public-health-in-cameroon-march-august-2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/seroprevalence-and-risk-factors-of-hepatitis-b-and-c-viruses-among-patients-at-angr-university-hospital-center-c-te-d-ivoire-2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/a-rare-case-of-abdominal-actinomycosis-and-colon-cancer 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/molecular-crosstalk-between-the-host-and-pathogen-in-streptococcus-pyogenes-virulence 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/changing-population-immunity-to-covid-19-in-the-context-of-infection-vaccination-and-emerging-sars-cov-2-variants 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/candida-auris-infections-are-global-health-challenge 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/host-brakes-on-viral-inflammation 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/susceptibility-to-sars-cov-2-infection-and-nasal-air-conditioning-ability 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/health-risk-among-justice-involved-youth-a-multi-risk-multigroup-study 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/common-infections-in-cancer-patients-narrative-review-and-clinical-pearls 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/avian-influenza-in-russia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/prevalence-of-mycobacterium-tuberculosis-and-risk-factors-among-internally-and-externally-displaced-populations-in-northwest-ethiopia-the-case-of-dabat-and-metema 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/should-we-test-and-treat-the-fever-triggers-or-the-fever-that-creates-the-immune-system-against-the-fever-triggers 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/a-new-universal-fever-definition-and-the-unscientific-nature-of-the-conservative-fever-definition 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/a-spatiotemporal-statistical-analysis-of-dengue-burden-and-mortality-in-southern-india-2005-2026 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/age-sex-diagnostic-modality-and-seasonal-patterns-of-malaria-test-positivity-routine-primary-health-care-laboratory-data-from-gombe-state-nigeria 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/assessment-of-hematological-hepatic-and-renal-parameters-among-hiv-infected-patients-based-on-duration-on-antiretroviral-therapy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/burkholderia-cepacia-infection-outbreak-in-an-oncology-set-up-investigation-and-infection-control-response 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/etiologic-involvement-of-enterovirus-and-human-bocavirus-in-acute-flaccid-paralysis-cases-in-india 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/early-change-in-proenkephalin-levels-from-day-1-to-day-3-predicts-7-day-mortality-in-septic-critically-ill-patients-a-single-center-cohort-study-from-indonesia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/predictors-of-durable-viral-suppression-among-people-living-with-hiv-plhiv-on-antiretroviral-treatment-in-almaty-kazakhstan 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/atypical-presentation-and-comorbidities-of-scrub-typhus-in-western-nepal-high-prevalence-of-afebrile-cases-severe-pyuria-and-exceptional-response-to-doxycycline 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2026/artificial-intelligence-driven-clinical-decision-support-for-differentiating-viral-and-bacterial-infections-to-reduce-antibiotic-misuse 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/binding-and-activation-of-fibrinolytic-components-to-group-a-streptococcus-pyogenes-enhances-microbial-pathogenicity 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/innovative-bactericidal-drugs-pulse-regimens-for-treatment-of-leprosy-advancing-towards-zero-leprosy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/transforming-immune-therapy-a-reverse-pathway-in-b-lymphocytes-for-super-antibody-technology-to-cure-infectious-diseases-and-cancer 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/scientific-traditional-chinese-medicine-for-low-cost-and-effective-prevention-detection-and-treatment-of-infectious-diseases 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-case-of-aortic-root-abscess-and-repeated-prosthetic-aortic-valve-dehiscence-in-the-setting-of-rare-infection-with-cellulosimicrobium-cellulans-and-corynebacterium-tuberculostearicum 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/ttv-virome-analysis-for-predicting-immune-dysfunction-and-clinical-outcomes-in-copd-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/mycobacterium-abscessus-complex-causing-rapidly-progressive-necrotizing-pneumonia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/water-quality-and-intestinal-health-assessment-of-access-to-treated-water-and-the-prevalence-of-endoparasitosis-in-manacapuru-interior-of-the-amazon-region 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/clinical-relevance-of-the-516-g-t-polymorphism-in-cyp2b6-and-its-effects-on-efavirenz-concentrations-in-patients-with-hiv-and-tuberculosis-a-meta-analysis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/from-myositis-to-mycosis-invasive-aspergillosis-in-a-patient-treated-for-presumed-autoimmune-disease 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/infectious-disease-risk-among-patients-prescribed-amoxapine-or-trifluoperazine-a-retrospective-cohort-study-using-real-world-data 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/analysis-of-measles-surveillance-data-from-the-regional-health-center-of-excellence-in-man-ivory-coast-january-2014-to-june-2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/emphysematous-cystitis-in-an-immunocompromised-patient-with-ovarian-cancer-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/tree-shrew-a-new-primate-like-small-animal-for-ebv-research 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/assessment-of-the-role-of-free-living-forest-mammals-as-a-potential-source-of-yersinia-enterocolitica-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/the-outcomes-of-cryptococcal-disease-in-hiv-positive-individuals-following-covid-19-infection-a-systematic-review-and-meta-analysis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-rare-polymicrobial-bloodstream-infection-in-end-stage-renal-disease-enterobacter-cloacae-and-dual-achromobacter-species-in-a-hemodialysis-patient 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/the-great-masquerader-strikes-again-neurosyphilis-presenting-as-general-paresis-of-insane-and-stroke-like-syndrome-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/surgical-site-infection-pre-and-post-covid-19-related-hygiene-protocols-in-gynaecological-oncology-is-there-a-difference-in-prevalence-and-severity-at-charlotte-maxeke-johannesburg-academic-hospital 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/clostridium-difficile-bacteremia-in-a-case-of-acute-appendicitis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/uncommon-complications-of-invasive-streptococcus-pneumoniae-post-dental-care 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/fast-nanotechnology-and-its-practical-applications 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/leading-through-crisis-saudi-arabia-s-experience-in-managing-covid-19-and-influencing-global-health-strategies 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/syn023-mab-cocktail-for-rabies-prophylaxis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/the-humanized-mice-transplanted-with-edited-ccr5-32-hematopoietic-stem-cells-are-resistant-to-hiv-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/analysis-of-acute-flaccid-paralysis-surveillance-data-in-cote-divoire-from-2021-to-2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/from-mystery-to-clarity-a-public-health-investigation-into-unexplained-deaths-in-the-himalayan-foothills-india 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/the-inherent-value-of-human-life-navigating-health-economics-and-ethics-in-services-for-prevention-of-mother-to-child-transmission-of-hiv 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-case-of-visceral-leishmaniasis-in-a-non-endemic-region 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/unveiling-the-uncommon-pathogenesis-of-streptococcus-gallolyticus-subspecies-pasteurianus-bacteremia-and-its-link-to-gastric-pathology 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-rare-encounter-disseminated-nocardiosis-following-myasthenia-gravis-treatment 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/tb-or-not-tb-a-cryptic-case-of-pleural-effusion-in-an-immunocompromised-host 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/bacteria-or-kidney-stones-which-came-first 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/seroprevalence-of-covid-19-among-people-aged-12-and-over-in-a-silent-district-case-of-zoukougbeu-ivory-coast-april-2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/genomic-study-of-various-virulence-factors-of-acinetobacter-baumannii-isolated-from-clinical-specimens-in-patients-with-vap-and-bloodstream-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-modulation-of-dna-methylation-of-vitamin-d-genes-a-connecting-link-between-vitamin-d-levels-and-grade-of-sars-cov-2-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/elimination-of-visceral-leishmaniasis-from-india-the-story 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/global-clinical-impact-of-the-burden-of-antibiotic-resistance 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/mosquito-vectors-adapting-to-salinity-from-coastal-environmental-changes-heighten-disease-transmission-risk 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/novel-functions-of-the-interferon-system-against-virus-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-case-of-possible-cmv-pneumonia-after-liver-transplantation-and-management-of-cmv-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/conserved-antisense-rnas-significantly-inhibit-pan-coronaviruses 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/key-thoughts-and-strategies-based-on-pbl-for-rapid-managing-of-suspected-gram-positive-bacterial-infection-in-icu 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/sepsis-or-hlh-solving-the-diagnostic-puzzle-in-multiorgan-failure 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/increased-incidence-of-nontyphoidal-salmonella-infections-following-covid-19-outbreak-is-it-an-impact-of-the-pandemic 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/species-identification-of-lactose-non-fermenting-isolates-from-ventilator-associated-pneumonia-using-vitek-2-and-maldi-tof-ms-a-comparative-study-with-next-generation-sequencing 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/whole-genome-sequencing-for-genetic-analysis-of-virulence-factors-of-nosocomial-extensively-resistant-klebsiella-pneumoniae-isolated-from-different-clinical-specimens-from-icus 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/management-of-infected-aortobifemoral-bypass-graft-with-ureteral-fistula-in-a-patient-with-complex-vascular-history-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/multifocal-invasive-syphilis-in-an-hiv-positive-male-mimicking-septic-emboli-and-testicular-malignancy-a-diagnostic-and-therapeutic-challenge 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/congenital-hhv-6-infection-and-the-clinical-significance-of-hhv6-positivity-on-the-film-array-meningitis-encephalitis-panel 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/post-covid-19-syndrome-is-associated-with-sex-and-severity-of-first-covid-19-episode-in-honduras 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/recent-advances-in-theserodiagnosis-of-tick-borne-borreliosis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/ecurrent-plasmodium-falciparum-infection-in-a-pediatric-traveler-following-artemisinin-based-combination-therapy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/the-importance-of-assessing-the-mental-health-of-nurses-and-midwives-from-covid-19 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/clinical-profile-and-selected-viral-genome-sequence-analysis-of-sars-cov-2-infected-pediatric-patients-in-a-tertiary-military-hospital-in-quezon-city-from-january-2021-july-2023-a-cross-sectional-study 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/a-rare-case-of-meningitis-and-septicemia-due-to-streptococcus-acidominimus 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/association-between-cardiometabolic-risk-factors-and-covid-19-severity-in-patients-of-a-rural-tertiary-hospital 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/from-gut-to-bladder-fecal-microbiota-transplant-for-c-difficle-yields-surprising-uti-remedy-in-immunosuppressed-patient 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/uncovering-predictors-of-the-2025-measles-resurgence-in-texas-ecologic-determinants-risk-patterns 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/delayed-diagnosis-of-measles-in-an-unimmunized-child 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/antibiotic-resistant-pattern-of-the-most-frequently-isolated-bacteria-of-healthcare-associated-infections-in-patients-in-an-intensive-care-unit-before-and-during-the-covid-19-pandemic 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/experimental-infection-and-in-contact-transmission-of-h9n2-avian-influenza-virus-in-crows 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2025/cardiovascular-complications-associated-with-human-immunodeficiency-virus-in-pediatric-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/the-mechanisms-of-innate-immune-responses-in-streptococcus-pyogenes-pathogenicity 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/immunosuppressive-medications-did-not-increase-the-risk-of-severe-covid-19-in-solid-organ-transplant-recipients-diagnosed-with-sars-cov-2-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/next-generation-proteomics-for-increased-access-to-infectious-disease-testing-for-both-human-and-animal-health 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/on-a-road-to-enhance-vsv-as-an-oncolytic-agent-deciphering-the-underlying-mechanisms-of-resistance-by-some-cancer-cells 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/blind-spot-a-case-of-ocular-syphilis-in-a-patient-with-hiv 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/coffee-industry-by-products-extracts-evaluation-of-the-repellent-effect-against-the-r-b-microplus-tick 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/wohlfahrtiimonas-chitiniclastica-bacteremia-a-rare-case-of-a-male-with-maggot-infested-lower-extremity-wounds 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/rare-case-of-clostridium-cadaveris-in-an-immunocompromised-patient-with-metastatic-rectal-adenocarcinoma 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/hyperlactatemia-in-septic-shock-unmasking-the-false-notion-an-intriguing-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/psoas-abscess-due-to-group-b-streptococcus-presenting-as-diabetic-ketoacidosis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/structural-deformations-in-the-superior-tubular-of-the-hypothalamus-and-their-impact-of-autoimmune-antibody-production-a-study-of-long-covid-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/to-study-the-bacteriological-episodes-of-urinary-tract-infection-in-different-age-group-with-relation-to-gender 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/bacli-a-potential-antibacterial-agent-against-hospital-acquired-lung-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/anti-streptococcus-mutans-anti-adherence-and-anti-acidogenic-activity-of-uvaria-chamae-p-beauv 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/genome-wide-identification-and-functional-analysis-of-dysregulated-alternative-splicing-profiles-in-sepsis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/studies-on-microbial-infections-associated-with-azoospermia-in-male-mouse-model-and-multifaceted-insights-into-the-potential-mechanisms-of-spermatogenic-failure 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/feuling-drug-research-and-development-process-with-patient-centric-and-clinically-relevant-animal-models 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/are-you-doing-enough-to-protect-high-risk-patients-from-waterborne-infections 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/analysis-of-some-societal-factors-constraining-covid-19-dengue-malaria-and-tick-borne-borreliosis-control 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/two-residues-in-vp2-contribute-to-the-enhanced-replication-and-pathogenicity-of-raccoon-dog-parvovirus 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/experience-and-advice-from-single-medical-center-what-we-have-learned-from-covid-19-to-unexplained-serious-pneumonia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/metagenomic-next-generation-sequencing-for-diagnosing-severe-leptospirosis-in-a-patient-suspected-covid-19-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/comorbidities-in-covid-19-patients-are-these-associated-with-vitamin-d-deficiency-and-sars-cov-2-infection-grade 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/exploring-association-between-host-factors-and-different-virulence-factors-of-enterococcus-spp-with-treatment-outcome-in-entrococcal-bsi-causing-blood-stream-infections 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/gram-negative-sepsis-by-multidrug-resistant-hafnia-alvei-in-a-76-year-old-man-with-multiple-sclerosis-and-neurogenic-bladder 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/identifying-key-proteins-associated-with-infertility-induced-by-sperm-immobilizing-staphylococcus-aureus-in-murine-vaginal-lavage-fluid 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/parvovirus-b19-infection-and-auto-immunity-diseases 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/a-rare-case-of-urogenital-schistosomiasis-in-an-african-asylum-seeker-diagnostic-and-management-challenges 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/microbiological-and-phytochemical-analysis-of-curcuma-longa-and-evaluation-of-the-antibacterial-activity-of-the-phytochemical-components 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/pulmonary-vascular-endothelial-injury-and-acute-pulmonary-hypertension-caused-by-covid-19-the-fundamental-cause-of-refractory-hypoxemia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/phenotypic-changes-in-salmonella-typhi 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/reactivated-disseminated-tuberculosis-in-pregnancy-despite-repeated-negative-afb-testing 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/a-comprehensive-intervention-for-tb-hiv-co-infected-patients-in-francistown-botswana-integrating-geriatric-principles-into-infectious-disease-care 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/covid-19-waves-with-associated-variants-scenario-in-pakistan 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/right-thalamic-abscess-in-a-caucasian-man-with-rheumatoid-arthritis-an-intriguing-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/evolutionary-trends-and-positive-selection-sites-in-major-sars-cov-2-variants 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/synthetic-interferon-exhibits-potent-antiviral-activity-across-both-dna-and-rna-viruses-with-reduced-pro-inflammatory-gene-induction 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/disseminated-histoplasmosis-in-post-transplant-patient-a-bone-marrow-biopsy-diagnosis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/incidence-of-influenza-a-in-covid-19-patients-admitted-during-covid-19-global-pandemic-in-a-multispecialty-hospital-in-rajasthan-india 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2024/profile-of-patient-with-acute-viral-hepatitis-an-8-year-observational-study-from-a-tertiary-care-centre 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/surveillance-of-healthcare-associated-infections-new-challenges-for-the-next-decade 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/ongoing-journey-targeting-citrullinated-histone-h3-cith3-for-early-diagnosis-and-treatment-of-sepsis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/answers-in-hours-a-prospective-clinical-study-for-rapid-detection-of-pathogens-and-antibacterial-resistance-in-surgical-patients-using-oxford-nanopore-sequencing 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/disseminated-histoplasmosis-presenting-as-isolated-acute-liver-injury-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-phase-ii-randomized-sham-controlled-dose-finding-study-of-the-rd-x19-treatment-device-in-individuals-with-mild-to-moderate-covid-19 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/in-vitro-characterization-of-the-sars-cov-2-nucleocapsid-protein 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/innate-receptor-pglyrp2-is-a-functional-sensor-and-hepatic-scavenger-for-hepatitis-b-virus 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/effects-of-the-natural-compound-on-sars-cov-2-spike-protein-mediated-metabolic-alteration-in-thp-1-cells-explored-by-the-1h-nmr-based-metabolomics-approach 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-case-of-sars-cov-2-induced-guillain-barre-syndrome-in-a-patient-with-concurrent-bacterial-infection-while-undergoing-chemotherapy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-case-of-leprosy-in-north-florida 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/diagnostic-performance-of-real-time-pcr-kits-for-the-detection-sars-cov-2-from-fecal-swab-in-covid-19-patient-rajavithi-hospital-thailand 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/epidemiology-of-laboratory-confirmed-measles-virus-cases-under-the-age-of-less-than-5-in-ethiopia-2017-2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-randomized-phase-3-clinical-study-to-evaluate-the-efficacy-and-safety-of-shr8008-oteseconazole-vs-fluconazole-in-subjects-with-vulvovaginal-candidiasis-vvc 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/characterization-of-dengue-virus-serotype-1-and-2-infection-in-human-dermal-fibroblasts 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/radiation-proctitis-with-recurrent-gastrointestinal-bleed-complicated-by-cytomegalovirus-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/the-activity-of-phmb-and-other-guanidino-containing-compounds-against-acanthamoeba 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/exploring-the-impact-of-plectranthus-amboinicus-l-extracts-on-antioxidant-system-and-cell-membrane-integrity-of-p-aeruginosa-pa01-and-s-aureus-nctc8325 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/innate-immune-response-to-hepatitis-b-virus-infection-recognition-and-spontaneous-viral-clearance-by-hepatic-sensor-pglyrp2 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-case-of-meningoencephalitis-due-to-dual-infection-with-streptococcus-pneumoniae-and-herpes-simplex-virus-1 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/infectious-diseases-as-a-medical-social-economic-and-humanitarian-problem 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/new-optical-and-nanotechnologies-for-the-treatment-of-infectious-diseases 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/mometasone-furoate-nasal-spray-on-recovery-of-long-term-olfactory-dysfunction-due-to-covid-19-a-systematic-review-and-meta-analysis-of-a-randomized-controlled-trials 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/emergencies-at-the-clinic-of-infectious-diseases 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/antibiotic-induces-barter-syndrome-a-systematic-review 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/meningococcal-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-rare-case-of-cerebral-phaeohypomycosis-tissue-biopsy-to-the-rescue 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/first-detection-of-wnv-rna-presence-in-field-collected-mosquitoes-in-cyprus 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/role-of-infectious-disease-intervention-and-medical-management-in-a-rare-case-of-aureobasidium-pullulans 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/applying-machine-learning-and-deep-learning-for-multiclass-classification-of-arboviral-diseases-a-comparative-analysis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/low-dimensional-analysis-of-environmental-factors-mediating-norovirus-outbreaks-from-food 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/radiofrequency-emf-irradiation-effects-on-pre-b-lymphocytes-undergoing-somatic-recombination 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/encephalopathy-an-unusual-presentation-of-mrsa-osteomyelitis-and-sepsis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/efficacy-and-safety-of-a-canadian-fecal-microbial-transplantation-fmt-program-for-multiply-recurrent-c-difficile 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/emerging-dna-sensing-mechanism-and-its-therapeutic-significance-against-the-infectious-and-cancer-like-diseases 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/antibiotic-prescription-practices-among-children-with-influenza-or-rsv-infection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/preventing-infectious-diseases-using-uv-leds-for-water-disinfection 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/hepatitis-b-vaccination-status-and-associated-factors-among-health-care-workers-in-public-health-centers-in-addis-ababa-ethiopia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/herpes-zoster-complicated-with-an-asymptomatic-irreversible-neurogenic-bladder-and-end-stage-renal-disease-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/deciphering-acidic-stress-response-of-brucella-melitensis-isolates-through-gene-expression-analysis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/guidance-on-ms-animal-model-development-experimental-autoimmune-encephalomyelitis-models-induced-by-different-myelin-oligodendrocyte-glycoproteins-exhibit-differentiated-pharmacological-responses 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/gram-negative-eskape-bacteria-bloodstream-infections-in-patients-during-the-covid-19-pandemic-in-a-mexican-hospital 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/covid-19-vaccines-for-optimizing-immunity-in-the-upper-respiratory-tract 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/treatment-of-indian-kala-azar-visceral-leishmaniasis-from-one-month-to-one-dose 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/familial-cold-autoinflammatory-syndrome-2-mimicking-marshall-syndrome 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/recombinant-protein-immunoblots-supporting-clinical-diagnosis-and-differentiation-of-babesia-microti-and-babesia-duncani-infections 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/role-of-fine-needle-aspiration-cytology-in-the-diagnosis-of-leprotic-lesions 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/determination-of-optimal-cut-off-value-of-anti-ds-dna-elisa-in-the-diagnosis-of-systemic-lupus-erythematosus-sle 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/effect-of-abcb1-abcc4-and-gstp1-gene-polymorphisms-on-the-response-and-toxicities-of-antiretroviral-therapy-in-bangladeshi-aids-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/the-methylation-status-of-vitamin-d-genes-in-correlation-with-interleukin-6-levels-in-cytokine-storm-in-severe-covid-19-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/removals-of-some-protozoan-coliphage-viruses-and-bacteria-from-the-drinking-water-via-reverse-osmosis-effects-operating-parameters 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/immunological-status-of-antibodies-of-human-parvovirus-b19-among-pregnant-women-with-spontaneous-abortion-fetal-mortality-and-non-immune-hydrops-fetalis-in-marrakesh-morocco 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/mortality-from-hiv-infection-in-russia-before-and-during-the-covid-19-pandemic 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/activation-of-sars-cov-2-spike-protein-by-a-fungal-protease-s 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/unraveling-potential-early-diagnostic-biomarkers-of-opisthorchis-viverrini-infection-through-comparative-immunoproteomics-of-the-sera-of-infected-mice-and-hamsters 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/oncogenic-potential-of-sars-cov-2-a-trouble-in-the-future 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/rapid-growing-mycobacteria-infection-an-entity-in-diagnosis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/from-crisis-to-resilience-rethinking-pandemic-response-strategies 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/isolated-renal-failure-without-respiratory-failure-severe-rhabdomyolysis-as-a-rare-presentation-of-covid-19-a-case-series 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/staphylococcus-pettenkoferi-a-first-case-report-on-abscess-formation 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/food-microbes-influenced-horizontal-transfer-of-lactam-resistance-genes-in-the-mouse-gut 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/ulceroglandular-tularemia-following-arthropod-bite-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-mysterious-tale-of-two-joints-and-two-bacteria 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/multifaceted-role-of-lipid-species-in-hepatitis-c-virus-replication-assembly-and-host-antiviral-response 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-case-report-of-leptospirosis-in-cattle-in-sicily-south-italy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/phylogenetic-relationship-of-toxoplasma-gondii-in-dolphins-stranded-in-sicily-south-italy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/a-biomolecular-survey-on-the-presence-of-zoonotic-bacteria-in-troglophile-bats-in-sicily-southern-italy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/environmental-surveillance-of-enteric-viruses-evaluation-of-urban-wastewaters-contamination-in-sicily-southern-italy 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2023/serological-aspects-of-the-specific-immune-response-in-patients-with-measles-of-different-ages-in-a-territory-with-a-high-incidence 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/universal-approach-to-achieve-surgical-care-during-covid-19-pandemic 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/antimicrobial-resistance-in-gastrointestinal-infections-a-review-of-the-literature 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/enhancing-anti-folic-acid-efficacy-of-cotrimoxazole-with-a-nano-stabilizing-agent-al4-sio4-3-3mg2sio4-2al2-mg3-sio4-3-for-a-new-anti-trypanosmosis-drug 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/the-intestinal-microbiota-impacts-of-antibiotics-therapy-colonization-resistance-and-diseases 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/outbreak-of-lumpy-skin-disease-in-cattle-thailand-2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/clinico-epidemiological-study-and-therapeutic-outcomes-of-cutaneous-leishmaniasis-an-emerging-disease-in-north-india 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/pulmonary-tuberculosis-presenting-as-lung-mass 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/cyst-like-structures-in-the-life-cycle-of-trichomonas-vaginalis-a-possible-non-sexual-mode-of-transmission 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/dengue-and-sars-cov2-co-circulation-early-warning-according-to-climate-variations-in-cuba 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/a-case-report-of-melanoma-as-acute-mastoiditis-in-a-10-month-old-female-child 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/investigation-of-a-suspected-case-of-diphtheria-at-the-eliazar-germain-hospital-center-p-tion-ville-haiti-june-27th-2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/investigation-of-a-suspected-case-of-measles-in-thomassin-p-tion-ville-haiti-may-2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/evaluation-of-the-tuberculosis-surveillance-system-in-the-south-region-haiti-april-2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/evaluation-of-the-covid-19-surveillance-subsystem-sud-haiti-may-2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/investigation-of-a-suspected-case-of-monkeypox-in-the-commune-of-carrefour-ouest-haiti-may-2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/epidemiological-profile-of-typhoid-at-wesleyen-hospital-in-la-gon-ve-2018-to-2020-west-haiti 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/evaluation-of-malaria-epidemiological-surveillance-system-south-department-haiti-2018-2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/assessment-of-the-role-of-uropathogens-in-reproductive-performance-of-male-mice 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/the-effectiveness-of-the-national-strategy-for-hiv-prevention-in-brazil 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/profile-of-rare-community-acquired-uropathogens-in-a-public-health-institute 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/a-rare-presentation-of-disseminated-tuberculosis-with-involvement-of-bone-marrow 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/removal-of-aichi-aiv-adenovirus-41-ad41-and-hepatitis-a-viruses-from-drinking-water-by-zero-valent-iron-zvi-containing-reverse-osmosis-membrane-reactor 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/prevailing-microorganisms-in-confirmed-covid-19-patients-admitted-to-the-medical-icu-of-a-tertiary-hospital-in-the-philippines 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/prevailing-microorganisms-in-confirmed-covid-19-patients-admitted-to-the-medical-icu-of-a-tertiary-hospital-in-the-philippines 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/role-of-bronchoalveolar-lavage-fluid-galactomannan-in-the-diagnosis-of-invasive-pulmonary-aspergillosis-in-non-neutropenic-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/transmission-dynamics-and-control-strategy-of-single-strain-dengue-disease 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/pulmonary-tuberculosis-mimicked-as-metastatic-lung-carcinoma-a-case-report 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/development-of-reverse-transcription-loop-mediated-isothermal-amplification-rt-lamp-assay-as-a-point-of-care-diagnostics-for-sars-cov-2 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/life-expectancy-in-pandemic-times 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/examining-interventions-that-aim-to-enhance-tb-treatment-adherence-in-southeast-asia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/a-retrospective-cohort-study-on-the-duration-of-dexamethasone-and-clinical-outcomes-of-chronic-kidney-disease-patients-on-dialysis-with-severe-to-critical-covid-19 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/objective-regressive-regression-as-a-function-of-infectious-entities-and-natural-disasters 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/a-rare-case-of-hepatosplenic-abscess-caused-by-sphingomonas-paucimobilis-in-an-immunocompetent-host 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/clinical-efficacy-of-cefazolin-for-enterobactriaceae-related-infections-a-marginal-structural-model-of-a-retrospective-cohort 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/detection-of-sars-cov-2-armored-rna-in-global-interlaboratory-harmonization-study 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/new-identification-of-pathogenic-bacteria-using-aptamers-a-review-of-literature 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/respiratory-virus-surveillance-among-outpatients-in-rural-zambia-in-2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/the-profile-of-the-patients-with-double-infection-hiv-and-tb-in-a-south-west-region-of-romania 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2022/tuberculosis-mimicking-as-clavicular-malignancy-primary-tuberculosis-of-the-clavicle 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/infections-in-decompensated-liver-disease-patients-a-review-of-the-literature 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/why-do-patients-still-have-potential-to-transmit-covid-19-despite-receiving-vaccination 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/an-analysis-of-infection-rates-following-midfacial-fractures-and-the-requirement-of-antibiotic-use-prior-to-surgery 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/risk-factors-and-antimicrobial-susceptibility-pattern-of-extraintestinal-pathogenic-escherichia-coli-isolates-recovered-from-community-children-in-southern-taiwan 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/is-the-mandatory-implementation-of-a-passport-for-covid-19-vaccine-reduce-the-transmission-or-not 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/mucormycosis-associated-with-covid-19-a-deadly-combination 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/leprosy-how-to-help-patients-with-relapses 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/recombinant-activity-gene-an-analysis-of-expression-profile-during-development-stages-of-pterophyllum-scalare 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/leprosy-clinical-spectrum 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/durability-of-response-to-sars-cov-2-bnt162b2-vaccination-in-patients-on-active-anticancer-treatment 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/utility-of-limulus-amebocyte-lysate-assay-as-a-diagnostic-aid-in-patients-with-sepsis 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/rare-atypical-manifestations-of-type-2-lepra-reactions-a-case-series 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/an-immunopathogenetically-based-therapy-program-for-atypical-chronic-active-herpesvirus-co-infections-associated-with-postvirus-chronic-fatigue-syndrome 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/unexpected-spiral-of-events 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/syphilis-during-pregnancy-at-the-primary-health-care-of-campos-eliseos-and-in-the-city-of-betim-a-readjustment-in-the-work-process-for-an-early-diagnosis-and-a-proper-treatment1-2 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/viral-pathogens-associated-with-acute-lower-respiratory-tract-infections-in-bulgaria 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/study-of-a-non-tb-mycobacterium-cohort-in-a-nhs-district-general-hospital 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/histoplasmosis-in-south-east-asia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/case-report-covid-19-pneumonia-and-dengue-fever-co-infection-in-an-individual-from-southeast-asia 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/mycobacterium-tuberculosis-and-coronavirus-interactions 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/combined-tuberculosis-hiv-infectious-in-russia-statistics-and-perspectives 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/genes-expression-analysis-of-macrophages-infected-with-staphylococcus-aureus-vs-macrophages-infected-with-salmonellae-enterica-in-mice 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/hiv-infection-is-an-independent-predictor-of-mortality-amongst-adult-individuals-with-reduced-level-of-consciousness-in-southwestern-uganda 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/retrospective-epidemiological-study 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/development-of-molecular-diagnostic-kits-for-infectious-diseases-based-on-real-time-pcr 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/primary-multiple-cerebral-hydatid-cysts-an-unusual-case-report-in-european-countries 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/exploring-the-phytochemical-based-inhibition-of-pona1-from-mycobacterium-tuberculosis-by-molecular-docking-dynamic-simulation-and-admet-studies 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/coronavirus-and-public-health-lessons 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/mucormycosis-of-maxilla-an-oral-and-maxillofacial-surgeons-perspective 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/covid-19-in-pediatric-patients-with-hematologic-malignancies-a-case-series 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/a-case-series-of-tuberculosis-in-confirmed-covid-19-patients 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/pediatric-encephalitis-in-the-setting-of-covid-19-a-case-series 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/covid-19-in-children-with-rheumatic-heart-disease-a-case-series 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/iodox-a-granular-scatter-disinfectant-characterized-by-quick-effectiveness-and-long-lasting-durability-application-as-a-disinfectant-against-livestock-infectious-diseases-and-infectious-pathogens 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/molecular-mechanisms-involved-in-tnf-and-ifn-enhancement-of-apoptosis-induced-by-clostridioides-difficile-toxin-b-in-enteric-glial-cells 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/applications-of-an-iodine-based-disinfectant-with-immediate-and-long-lasting-efficiency-avian-influenza-virus-inactivation-effect-by-iodine-doped-activated-carbon 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/iodox-spray-a-versatile-and-multipurpose-spray-disinfectant-anti-bacterial-anti-viral-anti-fouling-anti-mold-applications-for-pathogen-free-environments 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/iodine-doped-activated-carbon-as-innovative-tool-for-water-sanitation-and-treatment 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-program/2021/prevalence-of-toxoplasmosis-in-populations-of-tlacuaches-didelphis-albiventris-in-the-municipality-of-morelia-and-its-zoonotic-relationship 0.8 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/coronavirus-disease-covid-19 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pediatric-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/std-and-hiv-infection 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases-prevention-control-and-cure 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infection-immunity-and-inflammation 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pharmacology-of-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/blood-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/epidemiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/sepsis-septicemia 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/ebola-and-zika-viral-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/emerging-and-re-emerging-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-resistance-amr 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vaccine-development-and-immunization 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/global-health-and-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-infections-and-virology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/genomics-and-bioinformatics-in-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases-diagnostics-and-imaging 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infection-control-and-hospital-acquired-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases-and-aging 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases-and-public-health 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/innovative-therapies-and-drug-discovery 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/artificial-intelligence-and-big-data-in-infectious-disease-management 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/behavioral-and-social-aspects-of-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/non-communicable-diseases-and-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/emerging-technologies-in-infectious-disease-management 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases-and-neurology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clinical-case-reports 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pandemic-preparedness-global-strategies-for-mitigation-and-response 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/airborne-waterborne-and-foodborne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-diseases-in-immunocompromised-hosts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/one-health-approach-to-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/veterinary-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tropical-and-neglected-tropical-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/early-symptoms-of-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-disease-research 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/climate-change-and-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/subclinical-and-asymptomatic-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-fungal-and-parasitic-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/research-on-medicine-and-vaccine-for-covid-19 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/parasitology-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/causes-and-symptoms-of-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vaccines-and-vaccination 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/nosocomial-infections-control 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/veterinary-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fungal-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tropical-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/neuro-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/internal-medicine-for-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clinical-and-case-reports 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/plants-diseases-and-fungal-infection-control 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobials-antibiotics-antibacterial 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/market-analysis-of-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/orthopaedic-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/non-communicable-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/problems-in-infectious-disease-practice 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viruses-and-cancer 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/critical-care-and-its-applications 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/respiratory-syncytial-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/abacavir 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/abdominal-infection 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acanthamoeba-infection 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acanthamoeba-keratitis-infection 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acyclovir 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acinetobacter-infection 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acinetobacter-species 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acquired-immunodeficiency-syndrome 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/actinomyces-gerencseriae 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/actinomyces-israelii 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acute-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/adefovir 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acute-upper-respiratory-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/adult-non-flu-vaccines 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/adenovirus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/aetiological-agent 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/african-trypanosomiasis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/aids-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/acute-rheumatic-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/african-sleeping-sickness 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/airborne-transmission 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/allergic-respiratory-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/alphavirus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/alveolar-echinococcosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/amantadine 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/amebic-liver-abscess 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/amoebiasis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/anti-infective-therapies 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/anti-viral-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibiotic-resistance 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibiotics-for-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antifungals 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobials 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiprotozoans 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiretroviral-therapies 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiviral-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiviral-drugs 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiviral-responses 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/arbovirus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/arenavirus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/argentine-hemorrhagic-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/arthropod-borne-viruses 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/aspergillus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/astrovirus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/attenuated-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacillus-species 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-gastroenteritis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-meningitis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-pneumonia 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-vaccines 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-vaginosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacteriophages 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/balantidium-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bartonella-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/baylisascaris-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bed-bugs 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/beta-lactam-antibiotic 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bladder-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/blastocystosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/blastomycosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bloodstream-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/body-lice-infestations 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bolivian-hemorrhagic-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bone-and-joint-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/botulinum-toxin-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bourbon-virus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/brucella-species 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/campylobacter-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/candida-albicans 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/capillaria-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/cardiovascular-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/cat-scratch-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/catheter-related-urinary-tract-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/chickenpox 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/chikungunya 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/childhood-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/chlamydia-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/chronic-obstructive-pulmonary-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/climatic-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/cns-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/communicable-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/complicated-pulmonary-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/contagious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/cutaneous-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/cyclospora-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/cytomegalovirus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/deltaretrovirus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/dengue-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/directly-transmitted-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/drug-resistant-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/ear-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/ebola-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/emerging-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/epizootic-haemorrhagic-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/escherichia-coli-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/etiologic-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/exogenous-retroviruses 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/eye-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fasciolopsis-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fatal-epidemic-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/female-sexually-transmitted-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/foodborne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fungal-endophthalmitis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fungal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fungal-keratitis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fungal-sinusitis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/fungal-vaccines 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/gastroenteritis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/gastrointestinal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/genital-warts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/genitourinary-tract-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/genomic-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/germ-theory-of-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/german-measles 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/gnathostoma-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/gonococcal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/gonorrhoea 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/green-algae 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/group-a-streptococcal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/group-b-streptococcal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/haemophilus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/haemorrhagic-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hantavirus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/helicobacter-pylori-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hemorrhagic-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hendra-virus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hepatitis-b 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hepatitis-c 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hookworms 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/host-pathogen-interactions 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hpv-human-papillomavirus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/human-immuno-deficiency-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/human-papilloma-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/human-virus-interactions 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/influenza-a 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/influenza-b 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/intestinal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/intra-abdominal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/intravascular-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/invasive-meningococcal-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/isospora-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/japanese-encephalitis-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/joint-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/legionella-bacteria 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/leprosy 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/liver-fluke-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/lower-respiratory-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/lung-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/lysogenic-viruses 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/lytic-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/measles 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/meningitis-infection 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/mumps 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/musculoskeletal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/mycobacterial-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/neuroinfectious-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/nipah-virus-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/ocular-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/papillomavirus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/parasitic-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/perinatal-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pilus-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pinworm-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/plague 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pneumococcal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/protozoal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/protozoan-vaccines 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pseudoterranova-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pulmonary-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/reovirus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/respiratory-tract-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/retroviral-proteins 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/rotavirus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/roundworm-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/rubella 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/salmonella-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/scarlet-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/shigella-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/sinusitis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/smallpox 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/staphylococcal-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/surgical-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/swine-flu 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tapeworm-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tetanus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tick-bite-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tuberculosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tumor-viral-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/typhus-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/upper-respiratory-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/urinary-tract-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vaccine-preventable-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vaginal-candidiasis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/valley-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/varicella-zoster-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vector-borne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-hepatites 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-load 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/virus-replication 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/west-nile-fever 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/wound-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/zika-virus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/zoonotic-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/anti-infective-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/anti-infective-therapy 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibacterial-drug 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibiotic-discovery 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibiotic-sensitivity 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antifungal-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antifungal-resistance 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-agents 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-chemotherapy 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-drug-resistance 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-drugs 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-peptides 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-prophylaxis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-stewardship 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiparasitic-agent 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiparasitic-drugs 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiretrovirals 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiviral-research 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/applied-microbiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacterial-cell-biophysics 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacteriostatic-agent 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/beneficial-microbes 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/beta-lactam-antibiotics 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/broad-spectrum-antibiotic 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/diagnostic-microbiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/disinfectants 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/environmental-microbiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/eukaryotic-cell 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/genome-research 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/macrolides 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbial-biogeochemistry 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbial-sciences 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbiological-research 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbiology-and-immunology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbiology-spectrum 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microorganisms 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/molecular-biology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/multidrug-resistance 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/novel-antimicrobials 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/soil-microbiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/superbugs-and-superdrugs 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/therapeutic-drug-monitoring 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vaccines-and-immunology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/airborne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/angiostrongyliasis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibiotic-research 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antibiotic-stewardship 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiviral-therapies 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/aspergillosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/arthropod-borne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacteriology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/brucellosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/chagas-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/climate-change-and-microbial-threats 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clinical-and-applied-microbiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clostridioides-difficile 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/drug-discovery-and-development-for-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/emerging-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/evolutionary-genetics-of-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/foodborne-illness 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hansens-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/healthcare-associated-infections 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hib-disease 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hiv-aids 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/immunization 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/immunocompromised-host 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/immunotherapy-for-infectious-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-disease-and-molecular-diagnostics 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-disease-epidemiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-disease-modelling 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/malaria 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/medical-microbiology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/meningococcus 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbial-biotechnology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbial-ecology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbial-genomics 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbial-pathogenesis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/mucormycosis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/mycology 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/one-health-approach 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pandemic-preparedness 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/parasitic-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/personal-protection-equipment-ppe 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/schistosomiasis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/ticks-and-tick-borne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tuberculosis-and-other-mycobacterial-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-hepatitis 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/virology-research 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/waterborne-diseases 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infectious-disease-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/microbiologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/virologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bacteriologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/mycologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/parasitologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/epidemiologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/immunologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tropical-medicine-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infection-control-practitioners 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-resistance-experts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/hospital-epidemiologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vaccine-researchers 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/zoonotic-disease-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/medical-entomologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/nosocomial-infection-experts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/molecular-biologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/biotechnologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/bioinformaticians 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/diagnostic-laboratory-scientists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tropical-disease-researchers 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pandemic-preparedness-experts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antiviral-and-antibiotic-drug-developers 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/pathologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/infection-prevention-and-control-nurses 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clinical-microbiologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clinical-virologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/clinical-parasitologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/vector-borne-disease-experts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/one-health-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/global-health-security-experts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/biocontainment-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/immunopathologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/disease-surveillance-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/field-epidemiologists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/antimicrobial-stewardship-coordinators 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/tropical-infectious-disease-clinicians 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/viral-hemorrhagic-fever-researchers 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/outbreak-response-coordinators 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/zoonosis-control-specialists 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/emerging-pathogen-researchers 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/contagion-modeling-experts 0.9 https://infectious-diseases-conferences.magnusgroup.org/program/scientific-sessions/quarantine-and-isolation-policy-advisors 0.9 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/tentative-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/final-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/initial-announcement.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/conference-brochure.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/abstract-submission-sample.docx 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/sponsors-exhibitors.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/2025 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/past-events/9th-edition-of-world-congress-on-infectious-disease-2025-book.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/past-events/9th-edition-of-world-congress-on-infectious-disease-2025-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/2024 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-diseases-wcid-2024-abstract-book.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-diseases-wcid-2024-final-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/2023 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-diseases-wcid-2023-abstract-book.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-disease-wcid-2023-final-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/2022 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-diseases-wcid-2022-abstract-book.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-disease-wcid-2022-final-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/2021 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-diseases-wcid-2021-abstract-book.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/uploads/pdfs/infectious-disease-wcid-2021-final-program.pdf 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery/wcid-2025-orlando-florida-usa 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery/wcid-2024-baltimore-md-usa 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery/wcid-2023-boston-massachusetts-usa 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery/pharma-conference-2019-paris-france 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery/pharma-conference-2018-rome-italy 0.8 https://infectious-diseases-conferences.magnusgroup.org/gallery/pharma-conference-2017-valencia-spain 0.8